Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CCNI Antibody (C-term) Blocking Peptide | Login | CCNI Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| CLIP1 Antibody (N-term) Blocking Peptide | Login | CLIP1 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| FIP1L1 Antibody (C-term) Blocking Peptide | Login | FIP1L1 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| LY75 Antibody (Center) Blocking Peptide | Login | LY75 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| NKX3-1 Antibody (Center) Blocking Peptide | Login | NKX3-1 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| NAMPT Antibody (Center) Blocking Peptide | Login | NAMPT Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| SFRP1 Antibody (N-term) Blocking Peptide | Login | SFRP1 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| CGB5 Antibody (Center) Blocking Peptide | Login | CGB5 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| TRIB2 C-term Blocking Peptide | Login | TRIB2 C-term Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PPM1D Antibody (N-term) Blocking Peptide | Login | PPM1D Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| LTK Antibody (N-term) Blocking Peptide | Login | LTK Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| LTK Antibody (C-term) Blocking Peptide | Login | LTK Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| RET Antibody (N-term C166) Blocking Peptide | Login | RET Antibody (N-term C166) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| RET Antibody (C-term T1078) Blocking Peptide | Login | RET Antibody (C-term T1078) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| RET Antibody (N-term Q28) Blocking Peptide | Login | RET Antibody (N-term Q28) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| RET Antibody (C-term L1027) Blocking Peptide | Login | RET Antibody (C-term L1027) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| ROR1 Antibody (N-term) Blocking Peptide | Login | ROR1 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| ROR1 Antibody Blocking Peptide | Login | ROR1 Antibody Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| ROR2 Antibody (N-term) Blocking Peptide | Login | ROR2 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| ROR2 Antibody (C-term) Blocking Peptide | Login | ROR2 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| TYRO3 Antibody Blocking Peptide | Login | TYRO3 Antibody Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| TEK (TIE2) Antibody (N-term) Blocking peptide | Login | TEK (TIE2) Antibody (N-term) Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| ABL1 Antibody (N-term K219) Blocking Peptide | Login | ABL1 Antibody (N-term K219) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| c ABL (ABL1) Antibody (C-term) Blocking peptide | Login | c ABL (ABL1) Antibody (C-term) Blocking peptide | ||||||||||||||||
|
||||||||||||||||||
| ABL1 Antibody (N-term H246) Blocking Peptide | Login | ABL1 Antibody (N-term H246) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||


